SomnoMed Ltd (ASX: SOM) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
SomnoMed Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
SomnoMed Ltd (ASX: SOM)
Latest News
⏸️ Investing
Why the Somnomed Limited share price surged 11% today
⏸️ Investing
Why these 4 ASX shares have started the week with solid gains
⏸️ Investing
Why these 4 ASX shares have climbed higher today
⏸️ Investing
Why these 4 ASX shares have sunk like stones today
⏸️ Investing
S&P/ASX 200 finishes higher Wednesday: 9 shares you missed
⏸️ Investing
Why the Somnomed Limited share price is cratering today
⏸️ Investing
Why Somnomed Limited is among 4 shares falling today
⏸️ Investing
Why MesoBLAST limited is rocketing higher on FDA approval
⏸️ Investing
Why these 4 shares are soaring higher today
⏸️ Investing
ASX 200 slammed: 12 shares you should have been watching
⏸️ Investing
Is ResMed Inc. (CHESS) the best new software company on the ASX?
⏸️ Investing
Fisher & Paykel Healthcare Corp Ltd shares plunge: Is it a bargain?
SOM ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|---|---|---|---|---|
YesNo |
About SomnoMed Ltd
SomnoMed Ltd produces and sells oral treatment of sleep-related disorder devices. It manufactures and designs premium oral appliances for the treatment of sleep-disordered breathing relieving conditions. Its products include SomnoDent, SomTabs, Som Morning Repositioner and others. Its geographical segments include North America, Europe, and Asia-Pacific. Business operations consist of the production and sale of products treating sleep-disordered breathing, which is the onlyreportable segment. Substantial revenue is realized from the European region.
SOM Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
01 Nov 2024 | $0.31 | $-0.01 | -3.13% | 79,696 | $0.31 | $0.31 | $0.31 |
31 Oct 2024 | $0.32 | $-0.02 | -5.88% | 103,888 | $0.33 | $0.33 | $0.32 |
30 Oct 2024 | $0.34 | $0.01 | 3.03% | 10,010 | $0.34 | $0.34 | $0.34 |
28 Oct 2024 | $0.33 | $-0.02 | -5.71% | 48,336 | $0.34 | $0.35 | $0.33 |
25 Oct 2024 | $0.35 | $0.01 | 2.94% | 25,001 | $0.36 | $0.40 | $0.35 |
24 Oct 2024 | $0.34 | $0.02 | 6.15% | 29,726 | $0.33 | $0.34 | $0.33 |
23 Oct 2024 | $0.33 | $0.00 | 0.00% | 30,157 | $0.34 | $0.34 | $0.32 |
22 Oct 2024 | $0.33 | $0.00 | 0.00% | 12,826 | $0.33 | $0.33 | $0.32 |
21 Oct 2024 | $0.33 | $0.02 | 6.45% | 29,217 | $0.32 | $0.33 | $0.32 |
18 Oct 2024 | $0.31 | $-0.01 | -3.13% | 106,662 | $0.32 | $0.32 | $0.31 |
17 Oct 2024 | $0.32 | $0.00 | 0.00% | 15,613 | $0.32 | $0.33 | $0.32 |
16 Oct 2024 | $0.32 | $-0.05 | -13.51% | 294,293 | $0.34 | $0.34 | $0.32 |
10 Oct 2024 | $0.37 | $0.04 | 12.12% | 10,546 | $0.35 | $0.37 | $0.35 |
09 Oct 2024 | $0.33 | $-0.02 | -5.80% | 27,242 | $0.34 | $0.34 | $0.33 |
08 Oct 2024 | $0.35 | $-0.03 | -8.11% | 80,379 | $0.37 | $0.37 | $0.32 |
07 Oct 2024 | $0.37 | $-0.02 | -5.13% | 121,553 | $0.39 | $0.41 | $0.37 |
04 Oct 2024 | $0.39 | $0.00 | 0.00% | 1,765 | $0.39 | $0.39 | $0.39 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
23 Sep 2024 | Karen Borg | Buy | 12,238 | $5,384 |
On-market trade. share approximately
|
09 Sep 2024 | Karen Borg | Buy | 25,593 | $10,749 |
On-market trade. share approximately
|
01 Jul 2024 | Karen Borg | Issued | 575,000 | $155,250 |
Issue of options.
|
01 Jul 2024 | Amrita Blickstead | Issued | 575,000 | $155,250 |
Issue of options.
|
28 Jun 2024 | Amrita Blickstead | Issued | 750,000 | $189,375 |
Issue of options.
|
28 Jun 2024 | Karen Borg | Issued | 750,000 | $189,375 |
Issue of options.
|
08 May 2024 | Amrita Blickstead | Issued | 952,381 | $200,000 |
Rights issue.
|
08 May 2024 | Karen Borg | Issued | 476,191 | $100,000 |
Rights issue.
|
08 May 2024 | Michael Gordon | Issued | 111,971 | $23,513 |
Rights issue.
|
08 May 2024 | Gaetano (Guy) Russo | Issued | 952,381 | $200,000 |
Rights issue.
|
08 May 2024 | Hamish Corlett | Issued | 35,143,697 | $7,380,176 |
Rights issue.
|
22 Feb 2024 | Neil Verdal-Austin | Transfer | 160,000 | $64,000 |
Off-market transfer. Assuming off market transfer of shares
|
22 Feb 2024 | Neil Verdal-Austin | Transfer | 160,000 | $64,000 |
Off-market transfer. Assuming off market transfer of shares
|
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Mr Michael Gordon | Non-Executive Director | Aug 2020 |
Mr Gordon is a Director of K Sleep Holdings Pty Limited Koala, a direct to consumer household goods retailer. Michael was previously the CFO of Different Technologies, a property technology company, and before that Michael was CFO of Rokt, a marketing technology company with more than US$300m in revenue. Prior to Rokt, Michael was the Group CFO and MD of Group Services for Greenlit Brands Pty Limited. Greenlit Brands grew from a turnover of A$250m (Freedom) to a A$2.4 billion vertically integrated retailer based in Australia and New Zealand and included the brands, Freedom, Snooze, Fantastic, Plush, OMF, Best & Less and Harris Scarfe. Prior to Greenlit Brands, Michael spent ten years with PricewaterhouseCoopers in South Africa, the United Kingdom and Australia specialising in the retail and pharmaceutical industries with experience in audit, taxation M&A and IPOs.
|
Mr Gaetano (Guy) Alfred Gerrard Russo | Non-Executive ChairmanNon-Executive Director | Aug 2020 |
Mr Russo is an accomplished business leader with a commercial and customer focussed background working in Australia and internationally. In addition to Chairman of SomnoMed he is Chairman of Guzman y Gomez Mexican Kitchen (GYG), Australia's growing restaurant business. Previously, Guy has served as CEO, Wesfarmers Department Store Division (Kmart & Target); Managing Director, Kmart Australia & NZ; President, McDonald's Greater China; CEO McDonald's Australia Ltd and Chairman of onald McDonald House Children's Charities. Guy is perhaps well known in Australia for his leadership in turning Kmart into the largest and profitable retail department store in the country. He has been a member of YPO since 2006, served as a member of the Business Council of Australia, and won industry awards for leadership in diversity in employment.
|
Mr Benjamin(Ben) Gisz | Non-Executive Director | Oct 2024 |
--
|
Ms Amrita Blickstead | Executive DirectorJoint CEO | Feb 2024 |
Ms Blickstead is the former Chief Operating and Marketing Officer at eBay Australia. The foundation of her career began in medical devices as a Biomedical Engineer at Cochlear and Ventracor .
|
Ms Karen Borg | Executive DirectorJoint CEO | Feb 2024 |
Ms Borg has a career in the medical devices sector. She has led businesses within Johnson & Johnson Medical and ResMed, as well as health and industry organizations for state and federal government. Most recently, she was the CEO of Catholic Healthcare.
|
Mr Terence Anthony Flitcroft | Company Secretary |
-
|
|
Darren Collins | Chief Financial Officer |
-
|
|
Terence Anthony Flitcroft | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
HSBC Custody Nominees (Australia) Limited | 40,281,683 | 40.66% |
National Nominees Limited | 14,541,201 | 14.68% |
Equity Plan Services Pty Ltd | 4,617,834 | 4.66% |
Citicorp Nominees Pty Limited | 4,079,645 | 4.12% |
Dottie Investments Pty Ltd | 3,650,487 | 3.68% |
Howarth PAF Pty Ltd <The Howarth Foundation A/C> | 2,156,722 | 2.18% |
Belgove Pty Ltd | 2,053,265 | 2.07% |
Ginga Pty Ltd | 1,739,045 | 1.75% |
BNP Paribas Nominees Pty Ltd <ACF Clearstream A/C> | 1,703,127 | 1.72% |
Bond Street Custodians Ltd <Salter – D79836 A/C> | 1,600,000 | 1.61% |
J P Morgan Nominees Australian Pty Limited | 1,217,842 | 1.23% |
P Neustadt Holdings Pty Ltd <Belgove Super Fund A/C> | 1,082,171 | 1.09% |
Timbina Pty Ltd <Timbina Super Fund A/C> | 1,073,764 | 1.08% |
REM Medical Pty Ltd <Cocoon Super Fund A/C> | 876,135 | 0.88% |
Golden Words Pty Ltd | 775,399 | 0.78% |
Honne Investments Pty Limited | 600,000 | 0.61% |
Thirty Sixth Vilmar Pty Ltd | 591,993 | 0.60% |
The Mulloon Institute Ltd | 533,048 | 0.54% |
Howarth PAF Pty Ltd <Howarth Charitable Fund A/C> | 523,771 | 0.53% |
Mr Edward Palmisano | 484,631 | 0.49% |